Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
55
CWBHF Quote, Financials, Valuation and Earnings
Last price:
$0.75
Seasonality move
:
-24.18%
Day range:
$0.60 - $0.77
52-week range:
$0.05 - $0.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.38x
P/B ratio:
12.76x
Volume:
831.6K
Avg. volume:
1M
1-year change:
640.64%
Market cap:
$118M
Revenue:
$49.7M
EPS (TTM):
-$0.14
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CWBHF
Charlotte's Web Holdings, Inc.
|
$12.8M | -- | -19.22% | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$292.6M | $0.14 | 15.84% | -39.95% | $31.70 |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$1.2B | $1.50 | 89.86% | -58.59% | $457.00 |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$835M | $0.56 | 3.55% | 5.27% | $89.48 |
|
FOLD
Amicus Therapeutics, Inc.
|
$185M | $0.18 | 31.89% | 267.32% | $14.50 |
|
SVRA
Savara, Inc.
|
-- | -$0.12 | -- | -2.6% | $10.81 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CWBHF
Charlotte's Web Holdings, Inc.
|
$0.74 | -- | $118M | -- | $0.00 | 0% | 2.38x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$22.50 | $31.70 | $3.8B | 9.83x | $0.00 | 0% | 3.56x |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$318.65 | $457.00 | $42.3B | 141.18x | $0.00 | 0% | 11.45x |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$58.53 | $89.48 | $11.3B | 32.85x | $0.00 | 0% | 3.51x |
|
FOLD
Amicus Therapeutics, Inc.
|
$14.34 | $14.50 | $4.5B | -- | $0.00 | 0% | 7.01x |
|
SVRA
Savara, Inc.
|
$5.58 | $10.81 | $1.1B | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CWBHF
Charlotte's Web Holdings, Inc.
|
87.16% | -1.620 | 232.04% | 1.23x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
4.08% | 3.124 | 1.15% | 3.40x |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
79% | 0.880 | 5.64% | 2.51x |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
9.55% | -0.788 | 5.63% | 3.25x |
|
FOLD
Amicus Therapeutics, Inc.
|
61.73% | -0.359 | 9.99% | 1.72x |
|
SVRA
Savara, Inc.
|
24.02% | -2.483 | 4.83% | 7.42x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CWBHF
Charlotte's Web Holdings, Inc.
|
$3.8M | -$5.3M | -26.51% | -105.72% | -45.68% | -$5.5M |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$257.8M | $17.4M | 41.28% | 43.78% | 6.12% | -$52.7M |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$829.3M | $131.7M | 10.18% | 107.73% | 12.01% | $140.3M |
|
BMRN
BioMarin Pharmaceutical, Inc.
|
$614.5M | $99.8M | 5.33% | 5.89% | 11.16% | $56.6M |
|
FOLD
Amicus Therapeutics, Inc.
|
$156.8M | $15.9M | -4.09% | -12.36% | 8.61% | $16M |
|
SVRA
Savara, Inc.
|
-$76K | -$30.3M | -65.99% | -78.83% | -- | -$22.5M |
Charlotte's Web Holdings, Inc. vs. Competitors
-
Which has Higher Returns CWBHF or ACAD?
ACADIA Pharmaceuticals, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of 96.33%. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat ACADIA Pharmaceuticals, Inc.'s return on equity of 43.78%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M ACADACADIA Pharmaceuticals, Inc.90.77% $1.60 $1.3B -
What do Analysts Say About CWBHF or ACAD?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -66.21%. On the other hand ACADIA Pharmaceuticals, Inc. has an analysts' consensus of $31.70 which suggests that it could grow by 40.89%. Given that ACADIA Pharmaceuticals, Inc. has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe ACADIA Pharmaceuticals, Inc. is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 ACADACADIA Pharmaceuticals, Inc.11 5 1 -
Is CWBHF or ACAD More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.116, which suggesting that the stock is 11.598% more volatile than S&P 500. In comparison ACADIA Pharmaceuticals, Inc. has a beta of 0.661, suggesting its less volatile than the S&P 500 by 33.872%.
-
Which is a Better Dividend Stock CWBHF or ACAD?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ACADIA Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. ACADIA Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or ACAD?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are smaller than ACADIA Pharmaceuticals, Inc. quarterly revenues of $284M. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is lower than ACADIA Pharmaceuticals, Inc.'s net income of $273.6M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while ACADIA Pharmaceuticals, Inc.'s PE ratio is 9.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 2.38x versus 3.56x for ACADIA Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.2.38x -- $11.5M -$5.8M ACADACADIA Pharmaceuticals, Inc.3.56x 9.83x $284M $273.6M
-
Which has Higher Returns CWBHF or ALNY?
Alnylam Pharmaceuticals, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of 16.99%. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat Alnylam Pharmaceuticals, Inc.'s return on equity of 107.73%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M ALNYAlnylam Pharmaceuticals, Inc.75.6% $1.37 $3.8B -
What do Analysts Say About CWBHF or ALNY?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -66.21%. On the other hand Alnylam Pharmaceuticals, Inc. has an analysts' consensus of $457.00 which suggests that it could grow by 43.42%. Given that Alnylam Pharmaceuticals, Inc. has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe Alnylam Pharmaceuticals, Inc. is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 ALNYAlnylam Pharmaceuticals, Inc.15 7 0 -
Is CWBHF or ALNY More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.116, which suggesting that the stock is 11.598% more volatile than S&P 500. In comparison Alnylam Pharmaceuticals, Inc. has a beta of 0.361, suggesting its less volatile than the S&P 500 by 63.901%.
-
Which is a Better Dividend Stock CWBHF or ALNY?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alnylam Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. Alnylam Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or ALNY?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are smaller than Alnylam Pharmaceuticals, Inc. quarterly revenues of $1.1B. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is lower than Alnylam Pharmaceuticals, Inc.'s net income of $186.4M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while Alnylam Pharmaceuticals, Inc.'s PE ratio is 141.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 2.38x versus 11.45x for Alnylam Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.2.38x -- $11.5M -$5.8M ALNYAlnylam Pharmaceuticals, Inc.11.45x 141.18x $1.1B $186.4M
-
Which has Higher Returns CWBHF or BMRN?
BioMarin Pharmaceutical, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of -5.2%. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat BioMarin Pharmaceutical, Inc.'s return on equity of 5.89%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M BMRNBioMarin Pharmaceutical, Inc.68.65% -$0.24 $6.7B -
What do Analysts Say About CWBHF or BMRN?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -66.21%. On the other hand BioMarin Pharmaceutical, Inc. has an analysts' consensus of $89.48 which suggests that it could grow by 52.88%. Given that BioMarin Pharmaceutical, Inc. has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe BioMarin Pharmaceutical, Inc. is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 BMRNBioMarin Pharmaceutical, Inc.14 5 0 -
Is CWBHF or BMRN More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.116, which suggesting that the stock is 11.598% more volatile than S&P 500. In comparison BioMarin Pharmaceutical, Inc. has a beta of 0.248, suggesting its less volatile than the S&P 500 by 75.229%.
-
Which is a Better Dividend Stock CWBHF or BMRN?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BioMarin Pharmaceutical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. BioMarin Pharmaceutical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or BMRN?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are smaller than BioMarin Pharmaceutical, Inc. quarterly revenues of $895M. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is higher than BioMarin Pharmaceutical, Inc.'s net income of -$46.6M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while BioMarin Pharmaceutical, Inc.'s PE ratio is 32.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 2.38x versus 3.51x for BioMarin Pharmaceutical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.2.38x -- $11.5M -$5.8M BMRNBioMarin Pharmaceutical, Inc.3.51x 32.85x $895M -$46.6M
-
Which has Higher Returns CWBHF or FOLD?
Amicus Therapeutics, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of 0.91%. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat Amicus Therapeutics, Inc.'s return on equity of -12.36%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M FOLDAmicus Therapeutics, Inc.84.64% $0.01 $716.6M -
What do Analysts Say About CWBHF or FOLD?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -66.21%. On the other hand Amicus Therapeutics, Inc. has an analysts' consensus of $14.50 which suggests that it could grow by 1.12%. Given that Amicus Therapeutics, Inc. has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe Amicus Therapeutics, Inc. is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 FOLDAmicus Therapeutics, Inc.0 7 0 -
Is CWBHF or FOLD More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.116, which suggesting that the stock is 11.598% more volatile than S&P 500. In comparison Amicus Therapeutics, Inc. has a beta of 0.430, suggesting its less volatile than the S&P 500 by 56.973%.
-
Which is a Better Dividend Stock CWBHF or FOLD?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amicus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. Amicus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or FOLD?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are smaller than Amicus Therapeutics, Inc. quarterly revenues of $185.2M. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is lower than Amicus Therapeutics, Inc.'s net income of $1.7M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while Amicus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 2.38x versus 7.01x for Amicus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.2.38x -- $11.5M -$5.8M FOLDAmicus Therapeutics, Inc.7.01x -- $185.2M $1.7M
-
Which has Higher Returns CWBHF or SVRA?
Savara, Inc. has a net margin of -50.58% compared to Charlotte's Web Holdings, Inc.'s net margin of --. Charlotte's Web Holdings, Inc.'s return on equity of -105.72% beat Savara, Inc.'s return on equity of -78.83%.
Company Gross Margin Earnings Per Share Invested Capital CWBHFCharlotte's Web Holdings, Inc.32.61% -$0.04 $72M SVRASavara, Inc.-- -$0.14 $124.2M -
What do Analysts Say About CWBHF or SVRA?
Charlotte's Web Holdings, Inc. has a consensus price target of --, signalling downside risk potential of -66.21%. On the other hand Savara, Inc. has an analysts' consensus of $10.81 which suggests that it could grow by 93.77%. Given that Savara, Inc. has higher upside potential than Charlotte's Web Holdings, Inc., analysts believe Savara, Inc. is more attractive than Charlotte's Web Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CWBHFCharlotte's Web Holdings, Inc.1 0 0 SVRASavara, Inc.6 0 0 -
Is CWBHF or SVRA More Risky?
Charlotte's Web Holdings, Inc. has a beta of 1.116, which suggesting that the stock is 11.598% more volatile than S&P 500. In comparison Savara, Inc. has a beta of 0.311, suggesting its less volatile than the S&P 500 by 68.931%.
-
Which is a Better Dividend Stock CWBHF or SVRA?
Charlotte's Web Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Savara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Charlotte's Web Holdings, Inc. pays -- of its earnings as a dividend. Savara, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CWBHF or SVRA?
Charlotte's Web Holdings, Inc. quarterly revenues are $11.5M, which are larger than Savara, Inc. quarterly revenues of --. Charlotte's Web Holdings, Inc.'s net income of -$5.8M is higher than Savara, Inc.'s net income of -$29.6M. Notably, Charlotte's Web Holdings, Inc.'s price-to-earnings ratio is -- while Savara, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Charlotte's Web Holdings, Inc. is 2.38x versus -- for Savara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CWBHFCharlotte's Web Holdings, Inc.2.38x -- $11.5M -$5.8M SVRASavara, Inc.-- -- -- -$29.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
34
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
46
ZD alert for Mar 4
Ziff Davis, Inc. [ZD] is up 2.17% over the past day.
Buy
54
KORU alert for Mar 4
Direxion Daily MSCI South Korea Bull 3X Shares [KORU] is up 10.39% over the past day.
Sell
40
PSIX alert for Mar 4
Power Solutions International, Inc. [PSIX] is up 0.53% over the past day.
